FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3197707963> ?p ?o ?g. }

• W3197707963 abstract "Onychomycosis is a common skin and nail infection in diabetic mellitus (DM) patients. Treatments typically require topical and oral antifungals. Almost all tinea cases are cured with antifungals, but rare hard-to-heal infections can occur. These cases sometimes can result in an amputation. Plasma treatment is another option for tinea infections. Cold atmospheric plasma (CAP) was recently developed and has antibacterial, antifungal, and antiviral effects among others.1 Our service used plasma care®, made by terraplasma medical GmbH (Munich, Germany). This is the first report of the use of plasma care® in our country. Informed consent was obtained from the patient. A 80 years old female had DM (HbA1c 8.5%) with a history of a right foot below knee amputation and a left 4th toe amputation 3 years ago. She got onychomycosis on her left foot and nail. A KOH prep was positive. Cultures grew Trichophyton rubrum. She started treatment with topical antifungal ointment (Efinaconazole 10% solution and Luliconazole topical ointments). The treatment for 4 weeks was unsuccessful, as was oral antifungal treatment with Fosravuconazole l-Lysine Ethanolate (100 mg/day). The patient continued to get worse (Figure 1A). The patient therefore trialed plasma therapy. Plasma therapy treatment was performed 10 min once a day. One week later, the patient's foot had improved and her culture results were negative (Figure 1B). Her topical therapy was changed from antifungal ointment to moisture ointment with plasma therapy 2 weeks later (Figure 1C). The patient finished plasma therapy after a total of 3 weeks of treatment (Figure 1D). There were no adverse events related to plasma therapy. The use of plasma therapy has expanded into multiple fields. In the present case, a hard-to-heal ulcer and skin infection were treated with plasma. Plasma has potent anti-infection properties.2 There are few adverse effects associated with plasma care®, which includes mild heating and pain. In this case, the patient had DM and her right leg had already been amputated. She feared that her left leg would require amputation, however her foot tinea was resistant to healing despite general treatment. General treatments have a low healing rate for onychomycosis. The rate of Efinaconazole solution and Fosravuconazole l-Lysine Ethanolate capsule were 17.8% and 59.4%. Here we show that plasma treatment is a novel alternative treatment for hard-to-treat skin and nail onychomycosis. Plasma has an effective in the treatment of Trichophyton rubrum on toe nail onychomycosis in vivo.3 Plasma care® is compact size and individually packaged sterile attachment to prevent cross-contamination.4 This is because plasma treatment is easy to perform and has few side effects. During the first week of treatment, a para-medical treated the patient and taught her how to use plasma care®. The patient was able to treat herself by the second week of therapy. Plasma therapy appears to have potential efficacy against hard-to-heal toe nail and foot skin onychomycosis when used in conjunction with traditional treatments. We thank Enago for translation services. The authors declare no potential conflict of interest. This study was approved by the research ethics committee of Kasukabe Chuo General Hospital (Permission No. 2007-3). The data that support the findings of this study are available from the corresponding author upon reasonable request." @default.
• W3197707963 created "2021-09-13" @default.
• W3197707963 creator A5005853335 @default.
• W3197707963 creator A5056220285 @default.
• W3197707963 creator A5067500296 @default.
• W3197707963 date "2021-09-15" @default.
• W3197707963 modified "2023-10-02" @default.
• W3197707963 title "Treating hard‐to‐heal skin and nail onychomycosis of diabetic foot with plasma therapy" @default.
• W3197707963 cites W2014691433 @default.
• W3197707963 cites W2080965633 @default.
• W3197707963 cites W2586612916 @default.
• W3197707963 cites W3046872226 @default.
• W3197707963 doi "https://doi.org/10.1111/dth.15127" @default.
• W3197707963 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34505330" @default.
• W3197707963 hasPublicationYear "2021" @default.
• W3197707963 type Work @default.
• W3197707963 sameAs 3197707963 @default.
• W3197707963 citedByCount "1" @default.
• W3197707963 countsByYear W31977079632023 @default.
• W3197707963 crossrefType "journal-article" @default.
• W3197707963 hasAuthorship W3197707963A5005853335 @default.
• W3197707963 hasAuthorship W3197707963A5056220285 @default.
• W3197707963 hasAuthorship W3197707963A5067500296 @default.
• W3197707963 hasBestOaLocation W31977079631 @default.
• W3197707963 hasConcept C115076146 @default.
• W3197707963 hasConcept C134018914 @default.
• W3197707963 hasConcept C138885662 @default.
• W3197707963 hasConcept C141071460 @default.
• W3197707963 hasConcept C16005928 @default.
• W3197707963 hasConcept C191897082 @default.
• W3197707963 hasConcept C192562407 @default.
• W3197707963 hasConcept C2775874440 @default.
• W3197707963 hasConcept C2776202428 @default.
• W3197707963 hasConcept C2776204877 @default.
• W3197707963 hasConcept C2777852167 @default.
• W3197707963 hasConcept C2777858829 @default.
• W3197707963 hasConcept C2779548794 @default.
• W3197707963 hasConcept C41895202 @default.
• W3197707963 hasConcept C555293320 @default.
• W3197707963 hasConcept C71924100 @default.
• W3197707963 hasConceptScore W3197707963C115076146 @default.
• W3197707963 hasConceptScore W3197707963C134018914 @default.
• W3197707963 hasConceptScore W3197707963C138885662 @default.
• W3197707963 hasConceptScore W3197707963C141071460 @default.
• W3197707963 hasConceptScore W3197707963C16005928 @default.
• W3197707963 hasConceptScore W3197707963C191897082 @default.
• W3197707963 hasConceptScore W3197707963C192562407 @default.
• W3197707963 hasConceptScore W3197707963C2775874440 @default.
• W3197707963 hasConceptScore W3197707963C2776202428 @default.
• W3197707963 hasConceptScore W3197707963C2776204877 @default.
• W3197707963 hasConceptScore W3197707963C2777852167 @default.
• W3197707963 hasConceptScore W3197707963C2777858829 @default.
• W3197707963 hasConceptScore W3197707963C2779548794 @default.
• W3197707963 hasConceptScore W3197707963C41895202 @default.
• W3197707963 hasConceptScore W3197707963C555293320 @default.
• W3197707963 hasConceptScore W3197707963C71924100 @default.
• W3197707963 hasIssue "6" @default.
• W3197707963 hasLocation W31977079631 @default.
• W3197707963 hasLocation W31977079632 @default.
• W3197707963 hasLocation W31977079633 @default.
• W3197707963 hasOpenAccess W3197707963 @default.
• W3197707963 hasPrimaryLocation W31977079631 @default.
• W3197707963 hasRelatedWork W134615286 @default.
• W3197707963 hasRelatedWork W2089926417 @default.
• W3197707963 hasRelatedWork W2250069945 @default.
• W3197707963 hasRelatedWork W2294048977 @default.
• W3197707963 hasRelatedWork W2321102684 @default.
• W3197707963 hasRelatedWork W2378754651 @default.
• W3197707963 hasRelatedWork W2588644879 @default.
• W3197707963 hasRelatedWork W3204399739 @default.
• W3197707963 hasRelatedWork W2416412807 @default.
• W3197707963 hasRelatedWork W2758989016 @default.
• W3197707963 hasVolume "34" @default.
• W3197707963 isParatext "false" @default.
• W3197707963 isRetracted "false" @default.
• W3197707963 magId "3197707963" @default.
• W3197707963 workType "article" @default.